Effectiveness of tocilizumab for IgA vasculitis associated with idiopathic multicentric Castleman’s disease: Two cases and literature review
Modern Rheumatology Case Reports · 2026
DOI: 10.1093/mrcr/rxag014 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2026. Verfasst von Koji Suzuki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Castleman Disease, Antibodies, Monoclonal, Humanized, Immunoglobulin A, Vasculitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Idiopathic multicentric Castleman’s disease (iMCD) is a systemic lymphoproliferative disorder characterised by interleukin (IL)-6 overproduction. To date, several cases of iMCD with autoimmune features have been reported, and cases of iMCD complicated by IgA vasculitis have also been reported. IL-6 is reported to promote the production of galactose-deficient IgA1, a key pathogenic factor in IgA vasculitis. Therefore, IL-6 overproduction in iMCD may contribute to the development of IgA vasculitis in these cases. Here, we present two cases of iMCD complicated by IgA vasculitis, both successfully treated with tocilizumab, an IL-6 receptor blockade. Furthermore, our literature review identified two reported cases of iMCD complicated by IgA nephropathy, and one case of iMCD complicated by IgA vasculitis, all of which responded favourably to tocilizumab. Our cases and literature review suggest the pathogenic role of IL-6 in the development of IgA vasculitis in iMCD and the effectiveness of tocilizumab as a potential therapeutic option not only for iMCD itself, but also for IgA vasculitis in the setting of iMCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- Department of General Internal Medicine and Rheumatology, Gifu Municipal Hospital, Gifu, Japan.
ORCID-Profile: Koji Suzuki, Koichi Saito, Mitsuhiro Akiyama, Kanako Shimanuki, Jun Kikuchi, Yuko Kaneko
Zitieren
APA
Suzuki, K., Saito, K., Akiyama, M., Miwa, A., Shimanuki, K., Hiramoto, K., Kikuchi, J., & Kaneko, Y. (2026). Effectiveness of tocilizumab for IgA vasculitis associated with idiopathic multicentric Castleman’s disease: Two cases and literature review. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxag014
Vancouver
Suzuki K, Saito K, Akiyama M, Miwa A, Shimanuki K, Hiramoto K, et al. Effectiveness of tocilizumab for IgA vasculitis associated with idiopathic multicentric Castleman’s disease: Two cases and literature review. Modern Rheumatology Case Reports. 2026. doi:10.1093/mrcr/rxag014
BibTeX
@article{Suzuki2026,
author = {Suzuki, Koji and Saito, Koichi and Akiyama, Mitsuhiro and Miwa, Akari and Shimanuki, Kanako and Hiramoto, Kazuoto and Kikuchi, Jun and Kaneko, Yuko},
title = {Effectiveness of tocilizumab for IgA vasculitis associated with idiopathic multicentric Castleman’s disease: Two cases and literature review},
journal = {Modern Rheumatology Case Reports},
year = {2026},
doi = {10.1093/mrcr/rxag014}
}
EUVIMED